Exane Derivatives’s Allstate ALL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9
| Closed | -$1.25K | – | 777 |
|
|
2022
Q1 | $1.25K | Hold |
9
| – | – | ﹤0.01% | 790 |
|
|
2021
Q4 | $1.06K | Hold |
9
| – | – | ﹤0.01% | 704 |
|
|
2021
Q3 | $1.15K | Sell |
9
-473
| -98% | -$62.5K | ﹤0.01% | 845 |
|
|
2021
Q2 | $63.8K | Buy |
+482
| New | +$62.3K | 0.01% | 611 |
|
|
2021
Q1 | – | Sell |
-740
| Closed | -$81.3K | – | 899 |
|
|
2020
Q4 | $81.3K | Buy |
740
+373
| +102% | +$36.7K | 0.02% | 421 |
|
|
2020
Q3 | $34.5K | Hold |
367
| – | – | 0.01% | 396 |
|
|
2020
Q2 | $35.6K | Sell |
367
-320
| -47% | -$31.4K | 0.01% | 375 |
|
|
2020
Q1 | $63K | Hold |
687
| – | – | 0.02% | 337 |
|
|
2019
Q4 | $78.5K | Buy |
687
+148
| +27% | +$16.2K | 0.01% | 338 |
|
|
2019
Q3 | $58.6K | Hold |
539
| – | – | 0.01% | 360 |
|
|
2019
Q2 | $54.8K | Buy |
+539
| New | +$52.7K | 0.01% | 386 |
|
|
2019
Q1 | – | Sell |
-5,939
| Closed | -$491K | – | 653 |
|
|
2018
Q4 | $491K | Buy |
5,939
+5,358
| +922% | +$481K | 0.09% | 180 |
|
|
2018
Q3 | $57.3K | Buy |
581
+42
| +8% | +$4.1K | 0.01% | 364 |
|
|
2018
Q2 | $49.6K | Buy |
539
+22
| +4% | +$2.09K | 0.01% | 387 |
|
|
2018
Q1 | $49.1K | Sell |
517
-5
| -1% | -$484 | 0.01% | 352 |
|
|
2017
Q4 | $54.7K | Buy |
522
+355
| +213% | +$35K | 0.01% | 335 |
|
|
2017
Q3 | $15.3K | Buy |
167
+84
| +101% | +$7.64K | ﹤0.01% | 367 |
|
|
2017
Q2 | $7.34K | Buy |
83
+81
| +4,050% | +$6.87K | ﹤0.01% | 419 |
|
|
2017
Q1 | $163 | Hold |
2
| – | – | ﹤0.01% | 472 |
|
|
2016
Q4 | $148 | Hold |
2
| – | – | ﹤0.01% | 519 |
|
|
2016
Q3 | $138 | Hold |
2
| – | – | ﹤0.01% | 523 |
|
|
2016
Q2 | $140 | Hold |
2
| – | – | ﹤0.01% | 458 |
|
|
2016
Q1 | $135 | Buy |
+2
| New | +$126 | ﹤0.01% | 516 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | -$116 | – | 509 |
|
|
2015
Q3 | $116 | Hold |
2
| – | – | ﹤0.01% | 486 |
|
|
2015
Q2 | $130 | Hold |
2
| – | – | ﹤0.01% | 485 |
|
|
2015
Q1 | $142 | Sell |
2
-2,525
| -100% | -$178K | ﹤0.01% | 482 |
|
|
2014
Q4 | $178K | Buy |
+2,527
| New | +$166K | 0.02% | 231 |
|
Other funds holding ALL
Exane Derivatives's ALL Position: Q2 2022 in Review
Exane Derivatives sold out of Allstate (ALL) in Q2 2022, closing a stake of 9 shares — an estimated $1.25K sold.
Exane Derivatives first reported a position in ALL in Q4 2014 and held it in 27 quarters. The position peaked at $491K in Q4 2018. 1,251 funds tracked by Wall St. Rank hold ALL as of Q2 2022.
- Exane Derivatives reported no remaining Allstate position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 9 Allstate shares in Q2 2022, an estimated $1.25K.
- Exane Derivatives first reported a position in Allstate in Q4 2014 and held it in 27 quarters.
- Exane Derivatives's Allstate position peaked at $491K in Q4 2018.
- 1,251 funds tracked by Wall St. Rank held Allstate as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.